semaglutide versus tirzepatide side effects Subcutaneously administered vs for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia semaglutide versus tirzepatide side effects

Start your weight loss journey now

Mao Z-H, Gao Z-X, Liu D-W, Liu Z-S, Wu P

ZETLE L-karnitin takviyesine ynelik meta-analizler genellikle obez ve yal yetikinleri kapsamaktadr dolaysyla sonular dier bireyler iin genellenemeyecektir

The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)

The most common side effects of Wegovy are also GI-related, including nausea , diarrhea, vomiting, constipation , and abdominal pain